ASH 2013: Abstract 1943 - Dr.Lior Carmon
Thursday, March 28, 2024
Home
ASH 2013: Abstract 1943 - Dr.Lior Carmon
1 vote
PLAYING: ASH 2013: Abstr...
[ Show More ]
Lior Carmon, Vaxil Biotherapeutics Ltd., Nes-Ziona, Israel
Phase I/II study of Immucin, a pan-HLA, anti-MUC1 signal peptide vaccine in MM patients with residual disease or progression following autologous stem cell transplant.
Views: 7146
Playlists: 0
Downloads: 0
Category: science
Date: 2014-01-30 22:28:26
TOOLS: